Home / People / DoubleBlindPetition Urges FDA to Review Risks of Lykos Therapeutics' Bid for Legal MDMA DoubleBlindFri, May 3 Perspectives Scholars and concerned citizens file a public petition to the FDA to consider the unintended consequences of approving MDMA for PTSD therapy, as proposed by Lykos/MAPS. Will the FDA hear them out? https://t.co/GUDLiFW6eM1643Scholars and concerned citizens file a public petition to the FDA to consider the unintended consequences of approving MDMA for PTSD therapy.Read More Discover DoubleBlindNewsCannabisPsychedelicsAddictionDispensaryHealthOpioidsScience